financetom
Business
financetom
/
Business
/
Phreesia Insider Sold Shares Worth $294,559, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Phreesia Insider Sold Shares Worth $294,559, According to a Recent SEC Filing
Dec 13, 2024 1:33 PM

04:20 PM EST, 12/13/2024 (MT Newswires) -- David Linetsky, Senior Vice President, Life Sciences, on December 11, 2024, sold 11,853 shares in Phreesia ( PHR ) for $294,559. Following the Form 4 filing with the SEC, Linetsky has control over a total of 197,325 shares of the company, with 188,354 shares held directly and 8,971 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1412408/000112760224029339/xslF345X05/form4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
UAW to hold strike votes at Stellantis locals, union president says
UAW to hold strike votes at Stellantis locals, union president says
Sep 21, 2024
DETROIT (Reuters) -The United Auto Workers union plans to hold strike authorization votes at one or more of its Stellantis ( STLA ) locals in the coming days, union president Shawn Fain said on Tuesday, which could lead to a disruptive walkout against the Jeep maker. The UAW leader has in recent months called out Stellantis ( STLA ) CEO...
UAW union prepares to hold strike authorization votes at Stellantis locals
UAW union prepares to hold strike authorization votes at Stellantis locals
Sep 21, 2024
DETROIT, Sept 17 (Reuters) - The United Auto Workers union is planning to hold strike authorization votes at one or more of its Stellantis ( STLA ) locals in the coming days, union president Shawn Fain said in a video address on Tuesday evening, paving the way for a potentially disruptive walkout against the Jeep manufacturer. ...
Novo says Ozempic 'very likely' to be on 2027 Medicare negotiation list, Bloomberg News reports
Novo says Ozempic 'very likely' to be on 2027 Medicare negotiation list, Bloomberg News reports
Sep 21, 2024
(Reuters) - Danish drugmaker Novo Nordisk expects its diabetes drug Ozempic will very likely be on the U.S. government's 2027 list of price negotiations, Bloomberg News reported on Tuesday citing a company executive. Part of 2022's Inflation Reduction Act allows Medicare to negotiate prices for prescription drugs that had been particularly expensive for the federal health program which covers millions...
Novo says Ozempic 'very likely' to be on 2027 Medicare negotiation list, Bloomberg News reports
Novo says Ozempic 'very likely' to be on 2027 Medicare negotiation list, Bloomberg News reports
Sep 21, 2024
Sept 17 (Reuters) - Danish drugmaker Novo Nordisk expects its diabetes drug Ozempic will very likely be on the U.S. government's 2027 list of price negotiations, Bloomberg News reported on Tuesday citing a company executive. Part of 2022's Inflation Reduction Act allows Medicare to negotiate prices for prescription drugs that had been particularly expensive for the federal health program which...
Copyright 2023-2026 - www.financetom.com All Rights Reserved